On June 11 this year, our CCO, Damien Perriman, was part of a panel discussing the use of AI in biotech, as part of the World Bio Markets conference in The Hague, the Netherlands. You can watch the entire session in the video below here.
Monrovia, CA -- June 26, 2025 -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its role in the Meta-PURE initiative, a $9.2 million U.S. National Science Foundation (NSF) funded project under the CFIRE program aimed at transforming the scalability and accessibility of cell-free systems to expand real-world applications.
